Penny stocks are generally defined as securities issued by very small companies that trade at less than $5 per share.
These stocks are usually quoted over-the-counter, such as the OTC Bulletin Board (which is a facility of FINRA) or OTC Link LLC (which is owned by OTC Markets Group, Inc., formerly known as Pink OTC Markets Inc.).
But penny stocks may also trade on securities exchanges, like the New York Stock Exchange (NYSE).
These stocks can be very volatile, and it’s important that you understand all of the risks before investing in a microcap stock.
Not everyone has the risk tolerance to invest in microcap stocks, but for those that do, below is a list of NYSE penny stocks to watch in 2019.
With the DiscoverCI Stock Screener, we used the following criteria to identify these stocks:
The list also includes the beta of the stock so you can better understand the stock’s recent volatility.
The list is sorted by daily volume from high to low.
We update this list daily. Last updated: December 6th, 2019
Stay up to date with our latest trade ideas, stock market news, tips and posts.
We respect your privacy and take protecting it seriously.
© 2019 DiscoverCI
Disclaimer: DiscoverCI LLC is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on DiscoverCI.com represent a recommendation to buy or sell a security. The information on this site, and in its related application software, spreadsheets, blog, email and newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. In no event shall DiscoverCI.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any product, content or other material published or available on DiscoverCI.com, or relating to the use of, or inability to use, DiscoverCI.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related blog, email and newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way.